ANKS1A Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population of Jurkat cells carrying targeted disruption of the ANKS1A gene. This gene-edited cell pool provides a loss-of-function model for studying ANKS1A-dependent signaling and cellular functions. The knockout was generated using CRISPR/Cas9-mediated gene disruption, resulting in abrogation of full-length ANKS1A expression. As a polyclonal knockout population, these cells reflect a heterogeneous mixture of edited alleles, enabling robust functional interrogation without clonal bias.
The Jurkat cell line is an immortalized human T-lymphocyte line derived from a patient with T-cell acute lymphoblastic leukemia (T-ALL). Jurkat cells are extensively employed as a model for investigating T-cell receptor (TCR) signaling, apoptosis, and leukemogenesis. Their well-characterized signaling networks and ease of manipulation make them a preferred choice for functional genomics and drug screening in hematological malignancies.
ANKS1A functions as a scaffold protein that links activated receptor tyrosine kinases to intracellular signaling cascades. It interacts with Eph receptors (EphA2, EphB2) and platelet-derived growth factor receptor beta (PDGFR??). Upon ligand stimulation by ephrin-A1, ephrin-B1, or PDGF, ANKS1A recruits Src family kinases and adaptor proteins such as Grb2 and Cbl, thereby activating downstream Rho GTPases (RhoA, Rac1, Cdc42), the MAPK/ERK pathway, and the PI3K/AKT pathway. This signaling axis promotes actin cytoskeleton remodeling and cell migration. A representative signaling cascade is Ephrin-A1 ?? EphA2 ?? ANKS1A ?? Src ?? Rho GTPases ?? actin reorganization.
In Jurkat T-cells, ANKS1A is implicated in integrating signals from the microenvironment to regulate cytoskeletal dynamics and migratory behavior, processes critical for leukemia dissemination and immune cell function. Disruption of ANKS1A in this polyclonal knockout pool enables dissection of its role in T-ALL pathogenesis, particularly regarding cell adhesion, invasion, and response to growth factor stimuli. The model is valuable for elucidating how ANKS1A-mediated signaling contributes to aberrant proliferation and survival in leukemic T-cells.
Researchers can employ this knockout cell population in a variety of assays, including Western blotting to assess ANKS1A protein levels and phosphorylation of downstream effectors such as ERK and AKT, RT-qPCR to confirm gene disruption, and flow cytometry to monitor surface markers and apoptosis. Functional studies may include migration and invasion assays to evaluate cytoskeletal regulation, as well as co-immunoprecipitation to map ANKS1A interactions. The cells are suitable for drug target validation, functional genomics screens, and mechanistic studies of Ephrin and PDGFR signaling in T-cell leukemia. For additional information, contact Ascent Research.
